Interferon treatment for multiple sclerosis: autoimmune complications may be lethal.
Durelli
L
L
Dipartimento di Neuroscienze, Universita di Torino, Italy.
Bongioanni
M R
MR
Ferrero
B
B
Oggero
A
A
Marzano
A
A
Rizzetto
M
M
D000328:Adult; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016898:Interferon-alpha / Q000009:adverse effects*; D016899:Interferon-beta / Q000009:adverse effects*; D017093:Liver Failure / Q000139:chemically induced*; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy*; D011994:Recombinant Proteins / Q000009:adverse effects
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a